Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

WHO: More Oversight Needed after China’s Vaccine Scandal

By Drug Discovery Trends Editor | March 30, 2016

Dr. Lance Rodewald of World Health Organization (WHO) China's immunization program listens to questions during a press conference in Beijing, China, Tuesday, March 29, 2016. China must exert stronger oversight over vaccines sold on the private market in the wake of a developing scandal involving expired or improperly stored vaccines, the World Health Organization said Tuesday. (AP Photo/Ng Han Guan)China must exert stronger oversight over vaccines sold on the private market in the wake of a developing scandal involving expired or improperly stored vaccines, the World Health Organization said Tuesday.

Dr. Lance Rodewald of WHO China’s immunization program told reporters that the ongoing investigation into the “troubling” scandal that came to light last month would help identify ways to tighten regulation of the private market in vaccines.

“What we’re seeing here is problems on the private sector distribution side,” Rodewald said. “The vaccines that are in the private sector need to be managed, stored, handled, distributed and used in accordance with recognized standards.”

Chinese police say a woman and her daughter, who are now in detention, are thought to have sold nearly $100 million worth of the suspect products nationwide since 2011.

More than 130 people have been questioned and 69 criminal cases filed in connection with the pair. A total of 29 pharmaceutical companies are suspected of selling the faulty vaccines and 16 institutions of buying them.

The scandal reinforces long-standing public concerns over the safety of China’s food and medicine supply fed by scandals involving phony infant formula, snacks tainted with chemicals and phony or defective medications, including vaccines.

Rodewald said that the WHO has full confidence that vaccines in China “start their life safe, pure, potent and effective.”

He said that confidence applies both to the free and mandatory vaccines provided by the government for all children, as well as the voluntary vaccines available on the private market. Investigators say the latest scandal involves the voluntary, or secondary, vaccines, including those given to children to protect against maladies such as pneumococcal disease and rotavirus gastroenteritis.

Overseen by China’s Cabinet, a joint task force from the China Food and Drug Administration, the health ministry and national police force is investigating how the faulty vaccines entered the distribution network, the official Xinhua News Agency reported Monday.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE